·PIB·15 marks·250–350 wordsPolityEconomyS&T

"India's challenge is not generating knowledge but translating it from laboratories to markets." Discuss in light of recent initiatives such as ESTIC.

New · District CollectorCan you hold the district for 72 hours?Floods, a heatwave, an outbreak, a grievance queue. Take the decisions, see the consequences.Play →
In this answer
  1. Why translation is the binding constraint
  2. Recent initiatives bridging the gap
  3. Limits of the "translation only" view

India spends only 0.64% of GDP on R&D (GERD, 2020–21) [2]. Its bigger weakness, however, comes later: lab results seldom become products. ESTIC, the annual Emerging Science, Technology and Innovation Conclave, targets this "lab-to-market" gap. The statement is largely valid, but it understates how thin India's knowledge base still is.

Why translation is the binding constraint

  • Funding led by government: private firms fund only ~36% of GERD, against over 70% in China, South Korea and the US [2]. Firms are the actors that commercialise research.
  • Weak industry-academia link: publicly funded labs and universities produce papers, but few research results are licensed or co-developed with industry.
  • "Valley of death" for deep-tech: science-based startups face long gestation and no early revenue, and risk-averse investors avoid them.

Recent initiatives bridging the gap

  • ESTIC 2026 (27–29 October, Bharat Mandapam, inaugurated by the PM) brings scientists, policymakers and industry onto one platform and hosts a deep-tech startup exhibition [1].
  • PitchX at ESTIC 2025: 20+ deep-tech startups pitched directly to venture investors [3].
  • RDI Scheme: a ₹1 lakh crore fund launched at ESTIC 2025 [3]. It gives long-term, low-interest finance and equity through a special-purpose fund within ANRF [4].
  • TDB and BIRAC were designated second-level fund managers and opened calls for proposals in February 2026 [5].

Limits of the "translation only" view

  • Knowledge generation also lags: GERD has slipped from 0.66% to 0.64% of GDP [2], below the global average.
  • Slow money: RDI funds pass through layered fund managers. This delays the money reaching labs and startups [5].
  • Instrument mismatch: loans and equity [4] suit mature firms more than pre-revenue startups.
  • Activity over outcomes: conclaves report footfall, not follow-on funding or licences.

India's problem is therefore twofold: too little R&D spending, and weak conversion of research into products. Weak conversion is the more urgent of the two. ESTIC, the RDI Fund and ANRF are the right framework. They should be paired with a public outcome scorecard after each edition, faster R&D statistics and technology-transfer offices in universities. Together these can raise private R&D and help achieve SDG 9 and the Viksit Bharat 2047 vision of self-reliant innovation.

Sources

  1. 1PIB: Upcoming ESTIC-2026 to be held 27–29 October 2026 at Bharat Mandapam with inauguration by PM (Sept 2026)ESTIC 2026 dates, venue, PM inauguration, deep-tech exhibition
  2. 2PIB: Parliament reply on GERD as a share of GDP (7 August 2025)GERD 0.66%/0.66%/0.64% (2018–21); private share ~36% vs >70% in China, South Korea, US
  3. 3PIB: PitchX @ ESTIC 2025 Ignites India's DeepTech Future20+ startups pitched; ₹1 lakh crore RDI Scheme launched 3 November 2025 at ESTIC
  4. 4PIB: Cabinet Approves Research Development and Innovation (RDI) Scheme₹1 lakh crore corpus; long-term low-interest finance and equity; special-purpose fund within ANRF
  5. 5PIB: Parliament Question, Research, Development and Innovation (RDI) SchemeTDB and BIRAC designated second-level fund managers; calls opened February 2026
Practice
6 questions on this item
Check the answer for each question, or reveal all at once.
Practice MCQs →

More from this note

More on Polity